The Immune Deficiency Foundation's Research Grant Program funds innovative research to improve diagnosis, treatment, and understanding of primary immunodeficiency.
Funder: Immune Deficiency Foundation
Due Dates: September 14, 2026: Full application submission deadline
Funding Amounts: $25,000–$50,000 per award; one-year term; special recognition for top application (Michael Blaese Research Grant Award)
Summary: Supports innovative, patient-centered research to improve treatment, diagnosis, and understanding of primary immunodeficiency (PI).
Key Information: No animal model proposals or institutional overhead allowed; only one submission per applicant.
The Immune Deficiency Foundation's Research Grant Program funds patient-oriented research that advances the diagnosis, treatment, and management of individuals with primary immunodeficiency (PI). The program is intended to support clinicians and scientists conducting non-commercial research projects with a direct impact on the PI community, prioritizing innovative approaches and studies that address unmet needs and expand scientific understanding of PI.